Plant ID: NPO12214
Plant Latin Name: Leontice robustum
Taxonomy Genus: Leontice
Taxonomy Family: Berberidaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
ADORA3; | |
TSHR; | |
PTPN1; | |
BLM; | |
ACHE; | |
GRIA4; GRIK2; GRIA1; GRIK3; GRIK5; GRIK1; | |
SMN1;SMN2; | |
LMNA; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Ionotropic glutamate receptor | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | P48058 | CHEMBL3190 |
Ionotropic glutamate receptor | GRIK2 | Glutamate receptor ionotropic kainate 2 | Q13002 | CHEMBL3683 |
Ionotropic glutamate receptor | GRIA1 | Glutamate receptor ionotropic, AMPA 1 | P42261 | CHEMBL2009 |
Ionotropic glutamate receptor | GRIK3 | Glutamate receptor ionotropic kainate 3 | Q13003 | CHEMBL3684 |
Ionotropic glutamate receptor | GRIK5 | Glutamate receptor ionotropic kainate 5 | Q16478 | CHEMBL2675 |
Ionotropic glutamate receptor | GRIK1 | Glutamate receptor ionotropic kainate 1 | P39086 | CHEMBL1918 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Small molecule receptor (family A GPCR) | ADORA3 | Adenosine A3 receptor | P0DMS8 | CHEMBL256 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005215; transporter activity | GO:0015277; kainate selective glutamate receptor activity | 8.628E-13 | 2.087E-09 | GRIK1, GRIK2, GRIK3, GRIK5 |
BP | GO:0023052; signaling | GO:0060079; excitatory postsynaptic potential | 4.883E-12 | 9.667E-09 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
CC | GO:0044464; cell part | GO:0043204; perikaryon | 1.314E-08 | 1.590E-05 | GRIK2, GRIK3, GRIK5, SMN1, SMN2 |
MF | GO:0005215; transporter activity | GO:0008381; mechanosensitive ion channel activity | 6.709E-08 | 5.217E-05 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
CC | GO:0044456; synapse part | GO:0045211; postsynaptic membrane | 2.741E-07 | 1.865E-04 | GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
MF | GO:0005215; transporter activity | GO:0098782; mechanosensitived potassium channel activity | 1.101E-06 | 6.145E-04 | GRIK1, GRIK2, GRIK3, GRIK5 |
CC | GO:0032991; macromolecular complex | GO:0032983; kainate selective glutamate receptor complex | 1.463E-06 | 7.584E-04 | GRIK2, GRIK5 |
BP | GO:0032501; multicellular organismal process | GO:0007399; nervous system development | 2.276E-06 | 1.078E-03 | ACHE, GRIK1, SMN1, SMN2, TSHR |
MF | GO:0005215; transporter activity | GO:0004971; AMPA glutamate receptor activity | 2.924E-06 | 1.355E-03 | GRIA1, GRIA4 |
MF | Unclassified; | GO:0004872; receptor activity | 3.348E-06 | 1.488E-03 | ADORA3, GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5, TSHR |
CC | GO:0030054; cell junction | GO:0030054; cell junction | 8.594E-06 | 3.283E-03 | ACHE, GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
CC | GO:0044464; cell part | GO:0043005; neuron projection | 1.079E-05 | 3.981E-03 | GRIA1, GRIA4, GRIK3, GRIK5, SMN1, SMN2 |
CC | GO:0044456; synapse part | GO:0043195; terminal bouton | 1.118E-05 | 4.056E-03 | GRIK2, GRIK3, GRIK5 |
BP | GO:0051179; localization | GO:0034220; ion transmembrane transport | 1.902E-05 | 6.573E-03 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
MF | GO:0005488; binding | GO:0030165; PDZ domain binding | 2.994E-05 | 9.877E-03 | GRIA1, GRIK2, GRIK5 |
MF | GO:0005215; transporter activity | GO:0005234; extracellularly glutamate-gated ion channel activity | 1.125E-15 | 1.225E-11 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
BP | GO:0009987; cellular process | GO:0035235; ionotropic glutamate receptor signaling pathway | 9.524E-15 | 6.663E-11 | GRIA1, GRIA4, GRIK1, GRIK2, GRIK3, GRIK5 |
BP | GO:0023052; signaling | GO:0051967; negative regulation of synaptic transmission, glutamatergic | 4.417E-05 | 1.374E-02 | GRIK2, GRIK3 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 3.421E-12 | 9.578E-11 | GRIA1, GRIK5, ADORA3, GRIK3, GRIK1, GRIK2, TSHR, GRIA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04724 | Glutamatergic synapse | 8.688E-11 | 1.216E-09 | GRIA1, GRIK5, GRIK3, GRIK1, GRIK2, GRIA4 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 3.258E-04 | 2.447E-03 | GRIA1, TSHR, GRIA4 |
09160 Human Diseases | 09164 Substance dependence | hsa05033 | Nicotine addiction | 3.496E-04 | 2.447E-03 | GRIA1, GRIA4 |
09160 Human Diseases | 09164 Substance dependence | hsa05031 | Amphetamine addiction | 9.802E-04 | 5.489E-03 | GRIA1, GRIA4 |
09150 Organismal Systems | 09159 Environmental adaptation | hsa04713 | Circadian entrainment | 1.958E-03 | 8.835E-03 | GRIA1, GRIA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04723 | Retrograde endocannabinoid signaling | 2.209E-03 | 8.835E-03 | GRIA1, GRIA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04728 | Dopaminergic synapse | 3.571E-03 | 1.250E-02 | GRIA1, GRIA4 |
09120 Genetic Information Processing | 09122 Translation | hsa03013 | RNA transport | 6.252E-03 | 1.945E-02 | SMN2, SMN1 |
09120 Genetic Information Processing | 09124 Replication and repair | hsa03440 | Homologous recombination | 2.012E-02 | 5.633E-02 | BLM |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
G00-G99: Diseases of the nervous system G00-G99 | Myasthenia gravis | G70.0 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Spinal muscular atrophy | G00-G99 | SMN1;SMN2; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | ACHE; GRIK1; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | ACHE; ADORA3; |
G00-G99: Diseases of the nervous system G00-G99 | Epileptic seizures | G40, P90, R56 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | GRIK1; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poison intoxication | T36-T50 | ACHE; |
K00-K95: Diseases of the digestive system | Xerostomia | K11.7, R68.2 | ACHE; |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | ADORA3; |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE; |
NA: NA | Hepatitis C virus infection | NA | ADORA3; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | ACHE; |
I00-I99: Diseases of the circulatory system | Cerebrovascular ischaemia | I61-I63 | ADORA3; |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | ADORA3; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | ACHE; |
I00-I99: Diseases of the circulatory system | Ischemia | I99.8 | ADORA3; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | ADORA3; |
N00-N99: Diseases of the genitourinary system | Urinary dysfunction | N39.3-N39.4 | ACHE; |
NA: NA | Upper abdominal bloating | NA | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Myasthenia gravis diagnosis | G70.0 | ACHE; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poisoning due to pesticides and chemicals | T36-T50 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Mild cognitive impairment | F06.7 | ACHE; |
NA: NA | Early satiation associated with functional dyspepsia | NA | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE; |
C00-D49: Neoplasms | Cancer | C00-C96 | ACHE; ADORA3; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Alcohol use disorders | F10.2 | GRIK1; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | ACHE; |
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | GRIK1; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | GRIK1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | ACHE; |